Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10035761
Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
granted -
US 10034867
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 10034870
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
granted -
US 10034833
Sublingual and buccal film compositions
granted -
US 10035791
Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereof
granted -
US 10034919
Targeted human-interferon fusion proteins
granted -
US 10034866
Inhalable medicament comprising tiotropium
granted -
US 10034834
Compositions and methods for treating skin conditions
granted -
US 10034929
RNA interference functions as an antiviral immunity in mammals
granted -
US 10034934
Porcine epidemic diarrhea virus vaccines and methods of use thereof
granted -
US 10035832
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
granted -
US 10035845
Neutralizing antibodies to HIV-1 and their use
granted -
US 10035833
Vascular endothelial growth factor antagonists and methods of making
granted -
US 10036019
Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
granted -
US 10036751
Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment
granted -
US 10035846
Humanized pertussis antibodies and uses thereof
granted -
US 10035771
Mercaptonicotinic acid compound and preparation method and use thereof
granted -
US 10035822
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
granted -
US 10035802
Solid state forms of ibrutinib
granted -
US 10035844
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
granted -
US 10034916
Methods of treating a retinal disease by retinal pigment epithelial stem cells
granted -
US 10034871
Salts and compositions useful for treating disease
granted -
US 10030054
Campylobacter immunogenic compositions and uses thereof
granted -
US 10030024
Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.